fluorobenzenes has been researched along with Left Ventricular Hypertrophy in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (57.14) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Capoulade, R; Chan, KL; Clavel, MA; Côté, N; Després, JP; Dumesnil, JG; Mathieu, P; Pibarot, P; Tam, JW; Teo, KK | 1 |
Li, WH; Ma, YX; Xie, Q | 1 |
Chang, HJ; Chang, SA; Kim, DH; Kim, HK; Kim, YJ; Lee, HW; Oh, BH; Park, YB; Sohn, DW | 1 |
Ganguli, A | 1 |
Andresen, BT; Dellsperger, KC; DeMarco, VG; Ferrario, CM; Gutweiler, AA; Habibi, J; Johnson, MS; Ma, L; Schneider, RI; Sowers, JR; Whaley-Connell, AT | 1 |
Crijns, HJ; De Leeuw, PW; de Vos, C; Folkeringa, RJ; Habets, J; Pinto, YM; Prins, MH; Tieleman, RG; Van Dieijen-Visser, M | 1 |
Dong, XM; Liao, Y; Liu, L; Qu, XF; Yin, DC | 1 |
2 trial(s) available for fluorobenzenes and Left Ventricular Hypertrophy
Article | Year |
---|---|
Insulin resistance and LVH progression in patients with calcific aortic stenosis: a substudy of the ASTRONOMER trial.
Topics: Adult; Aged; Aortic Valve; Aortic Valve Stenosis; Calcinosis; Canada; Chi-Square Distribution; Disease Progression; Female; Fluorobenzenes; Hemodynamics; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertrophy, Left Ventricular; Insulin Resistance; Linear Models; Logistic Models; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Pyrimidines; Risk Assessment; Risk Factors; Rosuvastatin Calcium; Severity of Illness Index; Sulfonamides; Time Factors; Ultrasonography; Ventricular Function, Left; Ventricular Remodeling | 2013 |
No effect of rosuvastatin on left ventricular hypertrophy in patients with hypertension: a prospective randomised open-label study with blinded endpoint assessment.
Topics: Aged; Cholesterol, LDL; Endpoint Determination; Female; Fluorobenzenes; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Prospective Studies; Pyrimidines; Rosuvastatin Calcium; Sulfonamides | 2010 |
5 other study(ies) available for fluorobenzenes and Left Ventricular Hypertrophy
Article | Year |
---|---|
Rosuvastatin inhibits TGF-beta1 expression and alleviates myocardial fibrosis in diabetic rats.
Topics: Animals; Body Weight; Cardiomyopathies; Collagen; Creatine Kinase; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Fibrosis; Fluorobenzenes; Glycated Hemoglobin; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertrophy, Left Ventricular; Male; Natriuretic Peptide, Brain; Pyrimidines; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Rosuvastatin Calcium; Sulfonamides; Transforming Growth Factor beta1 | 2013 |
Effect of rosuvastatin on cardiac remodeling, function, and progression to heart failure in hypertensive heart with established left ventricular hypertrophy.
Topics: Animals; Blood Pressure; Collagen; Disease Progression; Fibrosis; Fluorobenzenes; Heart; Heart Failure; Hemodynamics; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hypertrophy, Left Ventricular; Myocardium; Organ Size; Pyrimidines; Random Allocation; Rats; Rats, Inbred Dahl; Rosuvastatin Calcium; Sulfonamides | 2009 |
Rosuvastatin in patients undergoing hemodialysis.
Topics: Cardiovascular Diseases; Confounding Factors, Epidemiologic; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperphosphatemia; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Phosphorus; Pyrimidines; Renal Dialysis; Rosuvastatin Calcium; Sulfonamides | 2009 |
Rosuvastatin ameliorates the development of pulmonary arterial hypertension in the transgenic (mRen2)27 rat.
Topics: Angiotensinogen; Animals; Fluorobenzenes; Heart Rate; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Pulmonary; Hypertrophy, Left Ventricular; Hypertrophy, Right Ventricular; Magnetic Resonance Imaging; Male; Membrane Glycoproteins; NADPH Oxidase 2; NADPH Oxidases; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidative Stress; Peptidyl-Dipeptidase A; Pulmonary Artery; Pyrimidines; rac1 GTP-Binding Protein; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Receptor, Angiotensin, Type 1; Rosuvastatin Calcium; Sulfonamides; Ventricular Function, Left; Ventricular Function, Right | 2009 |
[Sympathetic nerve in rat with pressure overload left ventricular hypertrophy].
Topics: Acyl Coenzyme A; Animals; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertrophy, Left Ventricular; Male; Myocardium; Pressure; Pyrimidines; Rats; Rats, Wistar; Rosuvastatin Calcium; Sulfonamides; Sympathetic Nervous System | 2009 |